Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Ager, Eleanor I ^a   Chong, Way W ^a   Wen, Shu wen ^a   Christophi, Christopher ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CASPASE 3; CYCLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PHOSPHOLIPASE A2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG TARGETING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER METASTASIS; LIVER WEIGHT; LUNG TOXICITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

EID: 77953940916     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-19     Document Type: Article

References (38)

1. McLoughlin JM, Jensen EH, Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control 2006, 13(1):32-41.
2. Lau WY, Lai EC. Hepatic resection for colorectal liver metastases. Singapore Med J 2007, 48(7):635-639.
3. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994, 343(8910):1405-1410. 10.1016/S0140-6736(94)92529-1, 7515134.
4. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer?. Trends Endocrinol Metab 2005, 16(7):293-299. 10.1016/j.tem.2005.07.009, 16061390.
5. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008, 29(9):1675-1684. 10.1093/carcin/bgn171, 18632755.
6. Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A, Kubota Y. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Molecular cancer therapeutics 2003, 2(11):1139-1147.
7. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth angiogenesis, and metastasis. Biochemical and biophysical research communications 2002, 294(2):441-447. 10.1016/S0006-291X(02)00496-5, 12051731.
8. Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol 2007, 22(4):577-584. 10.1111/j.1440-1746.2006.04797.x, 17376054.
9. Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circulation research 2001, 88(1):22-29.
10. Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Levy BI. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circulation research 2002, 90(10):1072-1079. 10.1161/01.RES.0000019892.41157.24, 12039796.
11. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. The Journal of clinical investigation 1995, 95(2):651-657. 10.1172/JCI117710, 295531, 7860748.
12. Pawlikowski M. Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas. Folia histochemica et cytobiologica/Polish Academy of Sciences Polish Histochemical and Cytochemical Society 2006, 44(3):173-177.
13. Ptasinska-Wnuk D, Lawnicka H, Fryczak J, Kunert-Radek J, Pawlikowski M. Angiotensin peptides regulate angiogenic activity in rat anterior pituitary tumour cell cultures. Endokrynologia Polska 2007, 58(6):478-486.
14. Hirano T, Ran J, Adachi M. Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats. Journal of hypertension 2006, 24(1):103-108. 10.1097/01.hjh.0000198030.30095.98, 16331107.
15. Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, Kawachi H. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. The American journal of pathology 2007, 170(6):1841-1853. 10.2353/ajpath.2007.060484, 1899458, 17525253.
16. Kuruppu D, Christophi C, Bertram JF, O'Brien PE. Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol 1996, 11(1):26-32. 10.1111/j.1440-1746.1996.tb00006.x, 8672738.
17. Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, Adachi M. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism: clinical and experimental 2006, 55(4):478-488.
18. Lemarie CA, Schiffrin EL. The angiotensin II type 2 receptor in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 11(1):19-31. 10.1177/1470320309347785, 19861349.
19. Shi ST, Li YF. Interaction of signal transduction between angiotensin AT1 and AT2 receptor subtypes in rat senescent heart. Chinese medical journal 2007, 120(20):1820-1824.
20. Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. The Angiotensin-I-converting Enzyme Inhibitor Perindopril Suppresses Tumor Growth and Angiogenesis: Possible Role of the Vascular Endothelial Growth Factor. Clinical Cancer Research 2001, 7:1073-1078.
21. Kosaka T, Miyajima A, Takayama E, Kikuchi E, Nakashima J, Ohigashi T, Asano T, Sakamoto M, Okita H, Murai M, et al. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate 2007, 67(1):41-49. 10.1002/pros.20486, 17044086.
22. Kowalski J, Belowski D, Madej A, Herman ZS. Effects of thiorphan bestatin and captopril on the Lewis lung carcinoma metastases in mice. Pol J Pharmacol 1995, 47(5):423-427.
23. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion angiogenesis, and peritoneal dissemination. Clin Cancer Res 2005, 11(7):2686-2694. 10.1158/1078-0432.CCR-04-1946, 15814650.
24. Gallagher PE, Tallant EA. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 2004, 25(11):2045-2052. 10.1093/carcin/bgh236, 15284177.
25. Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer research 2007, 67(6):2809-2815. 10.1158/0008-5472.CAN-06-3614, 17363603.
26. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Molecular cancer therapeutics 2009, 8(6):1676-1683. 10.1158/1535-7163.MCT-09-0161, 19509262.
27. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. The Journal of biological chemistry 1997, 272(30):19022-19026. 10.1074/jbc.272.30.19022, 9228085.
28. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. The Journal of clinical investigation 2003, 112(1):67-75. 162282, 12840060.
29. Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y, Murai M. Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer. Clin Cancer Res 2006, 12(9):2888-2893. 10.1158/1078-0432.CCR-05-2213, 16675585.
30. Clere N, Corre I, Faure S, Guihot AL, Vessieres E, Chalopin M, Morel A, Coqueret O, Hein L, Delneste Y, et al. Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. International journal of cancer 2010,
31. Abadir PM, Carey RM, Siragy HM. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 2003, 42(4):600-604. 10.1161/01.HYP.0000090323.58122.5C, 12953015.
32. Ratliff B, Sekulic M, Rodebaugh J, Solhaug MJ. Angiotensin II regulates nitric oxide synthase expression in afferent arterioles of the developing porcine kidney. Pediatric research 2010, 68(1):29-34.
33. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. The Journal of clinical investigation 1997, 100(2):264-269. 10.1172/JCI119531, 508188, 9218502.
34. Lee JH, Xia S, Ragolia L. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am J Physiol Regul Integr Comp Physiol 2008, 295(1):R144-154. 2494818, 18463192.
35. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006, 6(7):521-534. 10.1038/nrc1910, 16794635.
36. Namkoong S, Lee SJ, Kim CK, Kim YM, Chung HT, Lee H, Han JA, Ha KS, Kwon YG, Kim YM. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med 2005, 37(6):588-600.
37. Gallinat S, Busche S, Raizada MK, Sumners C. The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab 2000, 278(3):E357-374.
38. Rocken C, Rohl FW, Diebler E, Lendeckel U, Pross M, Carl-McGrath S, Ebert MP. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 2007, 16(6):1206-1212. 10.1158/1055-9965.EPI-05-0934, 17548686.